Wed, August 8, 2012
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ]: Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ]: Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ]: Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012

Cambrex To Announce Second Quarter 2012 Financial Results On August 1, 2012


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. ter-2012-financial-results-on-august-1-2012.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


Cambrex To Announce Second Quarter 2012 Financial Results On August... -- EAST RUTHERFORD, N.J. , July 26, 2012 /PRNewswire/ --

Cambrex To Announce Second Quarter 2012 Financial Results On August 1, 2012

[ ]

EAST RUTHERFORD, N.J., July 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: [ CBM ]) announced that second quarter 2012 financial results will be released on Wednesday, August 1, 2012 after the market closes.

The Company will host a conference call to discuss the second quarter 2012 financial results. 

 


Second Quarter 2012 Earnings Conference Call



When:                

Thursday, August 2, 2012 at 8:30 a.m. Eastern Time



Dial-in:                 

1-888-312-9841 for U.S.


1-719-325-2423 for International


Passcode:  4333709



Dial-in Replay:        

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode:  4333709


Available through Thursday, August 9, 2012



Webcast:              

[ www.cambrex.com ]

                                  

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit [ www.cambrex.com ].   

 

SOURCE Cambrex Corporation



[ Back to top ]

RELATED LINKS
[ http://www.cambrex.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear